InvestorsHub Logo
Followers 5
Posts 313
Boards Moderated 0
Alias Born 04/10/2013

Re: None

Monday, 09/16/2013 7:38:12 PM

Monday, September 16, 2013 7:38:12 PM

Post# of 403159
Possible BARDA funding?

Some 2013 contracts awarded-

Achaogen- 60MM to further the development of its drug plazomicin to treat patients with serious Gram-negative bacterial infections.

GSK- up to 200MM, new antibiotics + bioterrorism

Basilea Pharma-89MM for multidrug-resistant Gram-negative pathogens, including those that pose a bio threat.

Cempra- 58MM to develop late stage antibiotic Solithromycin ( bacterial pneumonia ) for bioterrorism aimed at pediatric population

Tetraphase- 67MM to develop new antibiotic effective against multidrug-resistant gram-negative pathogens

Could Brilacidin have utility for bioterrorism like Cempra's Solithromycin?

BARDA isn't just for influenza vaccines, anti radiation and bioterror. Food for thought :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News